ASCO to Hold On-Line ‘Virtual Meeting’ During Conference

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

ALEXANDRIA, Va-ASCO is going “virtual”-but with “real” CME credits. The American Society of Clinical Oncology will provide, for the first time, access to its annual meeting via the Internet at its website (www.asco.org).

ALEXANDRIA, Va—ASCO is going “virtual”—but with “real” CME credits. The American Society of Clinical Oncology will provide, for the first time, access to its annual meeting via the Internet at its website (www.asco.org).

ASCO’s “Virtual Meeting” will include audio clips and digitized slides from major scientific and educational sessions, made available shortly after their presentation. It will also offer a Virtual Poster Hall, where people can browse through more than 800 on-line poster presentations and an on-line map of the Exhibit Hall with a guide to exhibitors.

CME Credits

Physicians attending the on-line sessions can earn continuing medical education (CME) credits for up to a year after the ASCO meeting. Immediately following its May 15–18, 1999, sessions, ASCO will post scientific abstracts of the nearly 2,500 scientific presentations given at its 35th Annual Meeting in Atlanta, Georgia.

“The Internet is a valuable tool, and we’re using the technology to enhance the oncology community’s knowledge and understanding of the latest developments in cancer treatment and research,” said ASCO president Allen Lichter, MD. “We also hope that people living with cancer, their family members, and others will take advantage of this opportunity to access our annual meeting as well.”

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content